38th Annual New Treatments in Chronic Liver Disease CME Conference

This conference will review the latest medications and therapies in liver treatment and transplantation. The results of trials and real-world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases

Tickets: https://go.evvnt.com/2014107-0?pid=10018

Prices:
Physicians (MD, DO, MBBS): USD 250.00,
RN, NP, PA, Other: USD 200.00,
Students, Residents, Fellows: USD 50.00